Cue Biopharma files Form 3 for Chief Medical Officer, Head of R&D Dominique BoriePUBT·Jul 15 at 05:58 PMCUE-2.93%
U.S. stock market update: Cue Biopharma down 14.87%, executive appointments and financing raise concernsPrice Alert·Jul 13 at 12:22 PMCUE-2.93%
Biotech Stocks At 52-Week Highs: AMWL, CUE, ICCC, SRRK, FTHrttnews·Jul 13 at 06:18 AMSRRK-3.66%CUE-2.93%
Cue grants RSUs to CEO Shao-Lee Lin, CLO Sumita Ray and PAO Michael MeluzioTradingView·Jul 10 at 04:33 PMCUE-2.93%
Cue Biopharma Raises ~$50 Million in Private Placement With Cormorant, Columbia ThreadneedleTradingView·Jul 10 at 04:33 PMCUE-2.93%
Cue Biopharma Announces $50.0 Million Private Placement | CUE Stock NewsStockTitan·Jul 9 at 12:40 PMCUE-2.93%
U.S. stock market midday update: Cue BioPharma down 12.92% with no negative news, large volume fluctuations raise concernsPrice Alert·Jun 23 at 11:47 AMCUE-2.93%
Top Biotech Gainers: PMI Advances Artificial Heart, CUE Makes Board Changes, CING Up Despite CRLnasdaq·Jun 2 at 09:45 PMPMI0.00%CUE-2.93%
